Oxford BioDynamics plc (OBD) Ordinary 0.p Shares

Sell:0.45pBuy:0.50pNo change

Prices delayed by at least 15 minutes
Sell:0.45p
Buy:0.50p
Change:No change
Deal now
Prices delayed by at least 15 minutes
Sell:0.45p
Buy:0.50p
Change:No change
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Oxford BioDynamics Plc is a United Kingdom-based biotechnology company, advancing personalized healthcare by developing and commercializing precision clinical diagnostic tests for life-changing diseases. The Company is primarily engaged in the commercialization of proprietary molecular diagnostics products and biomarker research and development. Its products include EpiSwitch CiRT, EpiSwitch PSE, Specimen Submission Kit, and EpiSwitch Explorer. The EpiSwitch CiRT is a blood test which predicts an individual patient’s therapeutic response to checkpoint inhibitor immunotherapy. The EpiSwitch Explorer is a microarray kit for high-throughput, high-resolution 3D genome profiling. The Specimen Submission Kit is used for collecting samples from any location. The EpiSwitch platform offers reproducibly translating three-dimensional (3D) genome regulation for clinical applications. This platform provides a portfolio of clinical smart tests based on EpiSwitch technology.

Key people

Iain Gladstone Ross
Executive Chairman of the Board
Paul Stockdale
Chief Financial Officer, Executive Director
Alexandre Akoulitchev
Chief Scientific Officer, Executive Director
Stephen Diggle
Non-Executive Director
Peter Eric Presland
Non-Executive Director
David Mark Anthony Holbrook
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    OBD
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB00BD5H8572
  • Market cap
    £9.30m
  • Employees
    44
  • Shares in issue
    1.96bn
  • Exchange
    London Stock Exchange (LON)
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.